Collaborative online learning for trainees interested in hepatology | Founded by @hershshroff @LizzieAbyMD @paritapatelmd @adam_c_winters @alexsvogel | #MedEd
Calling all trainees!! 🩺 🌟 📣📣📣
Liver Fellow Network Applications are now open! Apply: https://t.co/MLBdm5QfRY
We foster med ed, networking and career development: for trainees, by trainees! 🧡
#Meded#Hepatology#LiverFellowNetwork#AASLD
🔬 #PathologyPearls by @li_peizi
Not every liver mass is malignant.
🧩 Segmental atrophy is a rare benign pseudotumor that can mimic hepatic malignancy on imaging and pathology.
🤔 Can less be more?
NAC is the cornerstone of acetaminophen toxicity treatment but can shorter regimens offer similar protection with better tolerability?
✨ Review the latest evidence
🩺 Explore practical clinical implications
📚 Key takeaways for clinicians
By: @IKhattib
📚🩺💡 New #LFNguidelines review! @BlaneyMD
Key highlights:
🔹 Diagnosis and evaluation of ascites
🔹 Prevention and management of SBP
🔹 Recognition and treatment of HRS
🔹 Practical, guideline-based clinical pearls
Read here ⬇️
🔗 https://t.co/yvO7PEh4EB
💧 Back-to-Basics infographic on the 'Approach to Ascites
A quick, trainee-friendly guide to:
✅ SAAG + ascitic protein interpretation
✅ Common etiologies and pathophysiology
✅ Ascites grading and treatment
✅ Diagnostic paracentesis and SBP definitions
👶🟡 Persistent jaundice in infancy can signal a time-sensitive diagnosis.
🌟Our newest Pathology Pearls article by @li_peizi itakes a closer look at biliary atresia, reviewing the key pathology features and their role in early diagnosis and improved outcomes.
📖 Read here⬇️
Can POCUS guide volume management in cirrhosis patients with AKI? 👀🩺
The latest #LFNevidencecorner highlights how POCUS may help assess volume status, guide management, and predict outcomes in cirrhosis ⚖️🌊
Check out the review ⬇️ 📚✨by @leandrosierraca
Can fibrosis in compensated MASH actually be reversed?
New therapies are pushing the conversation beyond slowing disease progression👀
🧬 Fibrosis improvement
📉 Disease activity
⚖️ Long-term outcomes
Where does efruxifermin fit into the evolving landscape of MASH treatment?
How should we approach gastric varices? 🤔
✍️ document classification, size & high-risk stigmata
🩻 obtain contrast-enhanced imaging with portal venous phase
👥 multidisciplinary discussion with hepatology, IR and advanced endoscopy
Option: EUS-guided coil injection therapy
👀 real-time assessment with doppler
💉🧵 hemostatic coils that act as scaffold for injected adjunct
Check it out 👇
“Endoscopic Management of Gastric Varices”
#LFNpearls@Edward_Cay